-
Something wrong with this record ?
Involvement of BKCa and KV potassium channels in cAMP-induced vasodilatation: their insufficient function in genetic hypertension
M. Pintérová, M. Behuliak, J. Kuneš, J. Zicha
Language English Country Czech Republic
Document type Journal Article, Research Support, Non-U.S. Gov't
NLK
Directory of Open Access Journals
from 1991
Free Medical Journals
from 1998
ProQuest Central
from 2005-01-01
Medline Complete (EBSCOhost)
from 2006-01-01
Nursing & Allied Health Database (ProQuest)
from 2005-01-01
Health & Medicine (ProQuest)
from 2005-01-01
ROAD: Directory of Open Access Scholarly Resources
from 1998
- MeSH
- Adrenergic beta-Agonists MeSH
- Cyclic AMP metabolism MeSH
- Vascular Resistance MeSH
- Potassium Channels, Voltage-Gated metabolism MeSH
- Hypertension genetics metabolism physiopathology MeSH
- Isoproterenol MeSH
- Blood Pressure MeSH
- NG-Nitroarginine Methyl Ester MeSH
- Rats, Inbred SHR MeSH
- Rats, Inbred WKY MeSH
- Nitric Oxide Synthase antagonists & inhibitors MeSH
- Large-Conductance Calcium-Activated Potassium Channel alpha Subunits metabolism MeSH
- Vasodilation * MeSH
- Animals MeSH
- Check Tag
- Male MeSH
- Animals MeSH
- Publication type
- Journal Article MeSH
- Research Support, Non-U.S. Gov't MeSH
Spontaneously hypertensive rats (SHR) are characterized by enhanced sympathetic vasoconstriction, whereas their vasodilator mechanisms are relatively attenuated compared to their high BP. The objective of our in vivo study was to evaluate whether the impaired function of BKCa and/or KV channels is responsible for abnormal cAMP-induced vasodilatation in genetic hypertension. Using conscious SHR and normotensive WKY rats we have shown that under the basal conditions cAMP overproduction elicited by the infusion of beta-adrenoceptor agonist (isoprenaline) caused a more pronounced decrease of baseline blood pressure (BP) in SHR compared to WKY rats. Isoprenaline infusion prevented BP rises induced by acute NO synthase blockade in both strains and it also completely abolished the fully developed BP response to NO synthase blockade. These cAMP-induced vasodilator effects were diminished by the inhibition of either BKCa or KV channels in SHR but simultaneous blockade of both K(+) channel types was necessary in WKY rats. Under basal conditions, the vasodilator action of both K(+) channels was enhanced in SHR compared to WKY rats. However, the overall contribution of K(+) channels to cAMP-induced vasodilator mechanisms is insufficient in genetic hypertension since a concurrent activation of both K(+) channels by cAMP overproduction is necessary for the prevention of BP rise elicited by acute NO/cGMP deficiency in SHR. This might be caused by less effective activation of these K(+) channels by cAMP in SHR. In conclusion, K(+) channels seem to have higher activity in SHR, but their vasodilator action cannot match sufficiently the augmented vasoconstriction in this hypertensive strain.
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc15033339
- 003
- CZ-PrNML
- 005
- 20151030140806.0
- 007
- ta
- 008
- 151016s2014 xr d f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.33549/physiolres.932718 $2 doi
- 035 __
- $a (PubMed)24397812
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xr
- 100 1_
- $a Pintérová, Mária $u Institute of Physiology, Academy of Sciences of the Czech Republic, Prague, Czech Republic $7 xx0102050
- 245 10
- $a Involvement of BKCa and KV potassium channels in cAMP-induced vasodilatation: their insufficient function in genetic hypertension / $c M. Pintérová, M. Behuliak, J. Kuneš, J. Zicha
- 520 9_
- $a Spontaneously hypertensive rats (SHR) are characterized by enhanced sympathetic vasoconstriction, whereas their vasodilator mechanisms are relatively attenuated compared to their high BP. The objective of our in vivo study was to evaluate whether the impaired function of BKCa and/or KV channels is responsible for abnormal cAMP-induced vasodilatation in genetic hypertension. Using conscious SHR and normotensive WKY rats we have shown that under the basal conditions cAMP overproduction elicited by the infusion of beta-adrenoceptor agonist (isoprenaline) caused a more pronounced decrease of baseline blood pressure (BP) in SHR compared to WKY rats. Isoprenaline infusion prevented BP rises induced by acute NO synthase blockade in both strains and it also completely abolished the fully developed BP response to NO synthase blockade. These cAMP-induced vasodilator effects were diminished by the inhibition of either BKCa or KV channels in SHR but simultaneous blockade of both K(+) channel types was necessary in WKY rats. Under basal conditions, the vasodilator action of both K(+) channels was enhanced in SHR compared to WKY rats. However, the overall contribution of K(+) channels to cAMP-induced vasodilator mechanisms is insufficient in genetic hypertension since a concurrent activation of both K(+) channels by cAMP overproduction is necessary for the prevention of BP rise elicited by acute NO/cGMP deficiency in SHR. This might be caused by less effective activation of these K(+) channels by cAMP in SHR. In conclusion, K(+) channels seem to have higher activity in SHR, but their vasodilator action cannot match sufficiently the augmented vasoconstriction in this hypertensive strain.
- 650 _2
- $a agonisté adrenergních beta-receptorů $7 D000318
- 650 _2
- $a zvířata $7 D000818
- 650 _2
- $a krevní tlak $7 D001794
- 650 _2
- $a AMP cyklický $x metabolismus $7 D000242
- 650 _2
- $a hypertenze $x genetika $x metabolismus $x patofyziologie $7 D006973
- 650 _2
- $a isoprenalin $7 D007545
- 650 _2
- $a vápníkem aktivované draslíkové kanály s vysokou vodivostí - alfa-podjednotky $x metabolismus $7 D051037
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a NG-nitroargininmethylester $7 D019331
- 650 _2
- $a synthasa oxidu dusnatého $x antagonisté a inhibitory $7 D019001
- 650 _2
- $a draslíkové kanály řízené napětím $x metabolismus $7 D024642
- 650 _2
- $a potkani inbrední SHR $7 D011918
- 650 _2
- $a potkani inbrední WKY $7 D011921
- 650 _2
- $a cévní rezistence $7 D014655
- 650 12
- $a vazodilatace $7 D014664
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Behuliak, Michal $7 xx0196023 $u Institute of Physiology, Academy of Sciences of the Czech Republic, Prague, Czech Republic
- 700 1_
- $a Kuneš, Jaroslav, $d 1948- $7 nlk19990073450 $u Institute of Physiology, Academy of Sciences of the Czech Republic, Prague, Czech Republic
- 700 1_
- $a Zicha, Josef, $d 1950- $7 jk01152609 $u Institute of Physiology, Academy of Sciences of the Czech Republic, Prague, Czech Republic
- 773 0_
- $w MED00003824 $t Physiological research Academia Scientiarum Bohemoslovaca $x 1802-9973 $g Roč. 63, č. 3 (2014), s. 275-285
- 856 41
- $u http://www.biomed.cas.cz/physiolres/ $y domovská stránka časopisu
- 910 __
- $a ABA008 $b A 4120 $c 266 $y 4 $z 0
- 990 __
- $a 20151016 $b ABA008
- 991 __
- $a 20151026152509 $b ABA008
- 999 __
- $a ok $b bmc $g 1095678 $s 916470
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2014 $b 63 $c 3 $d 275-285 $e 20140108 $i 1802-9973 $m Physiological research $n Physiol. Res. (Print) $x MED00003824
- LZP __
- $b NLK118 $a Pubmed-20151016